Latest statistics and disclosures from Barclays's latest quarterly 13F-HR filing:

• Top 5 stock holdings are SPY, SPY, EEM, IWM, GLD. These five stock positions account for 21.03% of Barclays's total stock portfolio.
• Added to shares of XOM (+$254.53M), MSFT (+$229.79M), WFC (+$98.05M), PG (+$96.37M), JNJ (+$88.25M), AIG (+$79.02M), XLY (+$76.11M), NWSA (+$58.13M), AAPL (+$55.79M), HRB (+$48.09M).
• Started new stock positions in Actavis, ALR-B, RIMG, DDF, Solarcity, IAT, OPOF, EGAN, Fortuna Silver Mines, BQR, PHYS, HEB, YAVY, BAMM, EDN, KYN, SFST, RCMT, VET, EIDO, PCM, KYE, AMRI, PPBI, GGT, FFKT, AGI, TAO, NTZ, CBAN, RBNF, AOD, TNH, VBR, ZNH, CASH, SURG, FSBK, IGOV, SOXL, DAVE, PFL, CHGS, GLP, DOL, AHC, VTV, MOG.B, ITF, PFSW, MXT, LMAT, FBIZ, AKO.A, PAC, KEP, HMNF, SBR, DES, UCFC, NDZ, RUK, PUK, PZA, PVD, MVV, IRIX, EXT, GPIC, POPE, CTCM, ASRV, SCR, FLL, CBS.A, DXJ, DON,
• Reduced shares in these stocks: IYR (-$217.75M), TU (-$110.99M), XLI (-$97.28M), WMT (-$77.24M), IBM (-$72.71M), JPM (-$67.77M), GLD (-$50.69M), FCX (-$43.67M), MDY (-$41.77M), VZ (-$41.58M).
• Sold out of its positions in Acelrx Pharmaceuticals, Allegheny Technologies Inc note 4.250% 6/0, Notes, AWF, AB, ALNC, Alon Usa Partners Lp ut ltdpart int, CARESOURCE HLDGS In, American Midstream Partners Lp us equity,
• As of March 31, 2013, Barclays has $73.00B in assets under management (AUM). Assets under management dropped from a total value of $73.28B to $73.00B.
• Independent of market fluctuations, Barclays was a net buyer by $658.49M worth of stocks in the most recent quarter.